Tuesday, November 13, 2007

Low-Cost Weight Loss Surgery (WLS) With Unique Price Guarantee

SAO PAULO, Brazil, Nov. 13 /PRNewswire/ -- Many people want or need weight loss surgery. Many are not covered by health insurance. They need a low-cost, safe and fixed-price alternative. Franco e Rizzi(http://www.robertorizzi.com) offers a unique surgical program with a fixed price of $11,497 (cost of surgical complications included).

Obese people without insurance coverage are obliged to search seriously for the best obesity surgery price and service their money can buy.

Search the web! Estimates are easy to obtain. What is not easy is obtaining a firm commitment! Most estimates do not include costs for extra materials and instruments possibly required during the surgery or recovery period. Extra material costs, extra days in the hospital or even one or more days in intensive care can be a severe gastric bypassblow to any budget.

Having a guaranteed price therefore assists in obtaining better terms for financing the surgery.

"I was amazed at how many people need this operation but are not covered by medical insurance. I want to offer the opportunity for such people to have safe and affordable obesity surgery at a fixed cost," says Dr Roberto Rizzi, who has been active in laparoscopic surgery in Brazil since 1992. "After consulting with my multi-disciplinary team, we were able to structure a package which includes laparoscopic gastric bypass surgery in one of the best hospitals in Brazil, the renowned Hospital Sao Luiz (http://www.saoluiz.com.br/internacional), pre and post-care follow-up and the excellent services of Great Start Ltda
(http://www.greatstartinbrazil.com) to manage local transport, patient coordination and assistance. All at a fixed cost, even if complications should occur during the surgery."

The first patient under this "all unforeseen surgery costs included" program was Mrs. Siumara Teixeira, who flew from New York to Brazil to get the weight loss surgery: "I could tell the medical staff and hospital took extraordinary care to ensure everything would run smoothly and without complications. I was on a tight budget, and it was a relief to know I would not have any unforeseen extra costs."

Ruy Bevilacqua (Corporate Medical Director of Hospital Sao Luiz) confirms their support of this unique program structured by Dr. Roberto Rizzi. "We know we have a very efficient facility and all the latest technology at his disposal, and having worked with Dr. Rizzi for twenty years, we feel more than confident of his 'patient's safety first' approach."

About Franco e Rizzi
Dr. Roberto Rizzi and his team have performed more then 3,000 laparoscopic surgeries. His team is specialized in Laparoscopic Gastric Bypass Surgery as well as other bariatric related surgeries. Dr. Rizzi's team of professionals includes a dietitian, a psychologist, a physiotherapist, a physician, anesthesiologists and plastic surgeons, all specialized in obesity treatment.

More Players In USA Obesity Lap-Band Market

Associated Press reported yesterday that Allergan Inc., which makes Botox and sells surgical weight-loss devices, will co-promote its Lap-Band product with health care products provider Covidien Ltd.

The Lap-Band is an adjustable gastric band, a device surgically implanted around the stomach to help severely obese patients lose weight by forcibly limiting food intake. The procedure is an alternative to more invasive gastric bypass surgery, commonly known as stomach stapling.

Under the multi-year agreement, which became effective Nov. 9, Covidien will co-promote Allergan's Lap-Band to bariatric and other surgeons in the United States. Pembroke, Bermuda-based Covidien makes medical devices and pharmaceutical products.

Covidien's sales representatives will help educate and train surgeons on the Lap-Band procedure, which costs roughly $12,000 to $20,000. Irvine, Calif.-based Allergan said it will continue to recognize revenue from the Lap-Band. Other financial terms of the deal weren't disclosed.

Allergan acquired the Lap-Band with its 2006 purchase of Inamed.

In late September, the Food and Drug Administration cleared Johnson & Johnson's Realize gastric band, effectively ending Allergan's dominance in the adjustable gastric banding market.